Critical evaluation of ceftolozane–tazobactam for complicated urinary tract and intra-abdominal infections

Giancola SE, Mahoney MV, Bias TE, Hirsch EB

Therapeutics and Clinical Risk Management 2016, 12:787-797

Published Date: 19 May 2016